Preclinical Evaluation of PTK7-Targeted Radionuclide Therapy
Kim Lindland, Sara Westrøm, Srdan M. Dragovic, Ruth Gong Li, Marion Masitsa Malenge, Betty Ho, Asta Juzeniene, Tina Bjørnlund Bønsdorff
This study evaluates PTK7-targeted radionuclide therapy using an antibody conjugate, showing tumor growth inhibition in a preclinical ovarian cancer model.
Molecular Cancer Therapeutics · Jun 10, 2025Peer-reviewedCancer Biology